Corvus Pharmaceuticals Logo

Corvus Pharmaceuticals

🇺🇸
CRVS
US2210151005

Corvus Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative therapies for cancer and autoimmune diseases. The company focuses on the research of targeted immunotherapies aimed at improving patient care and advancing medical treatment standards.

Next Quarterly Earnings

Thursday, October 29, 2026
CW 44
After-Hours
In 63 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 1, 2026

Stock Price

Frequently asked questions

When will Corvus Pharmaceuticals report its next quarterly earnings?

Corvus Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Corvus Pharmaceuticals last report quarterly earnings?

Corvus Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.19 USD.

How does Corvus Pharmaceuticals stock react to earnings?

Across its last 3 earnings reports, Corvus Pharmaceuticals stock moved by ±3.8% on average the following day. The largest reaction was +6.6% on 05/07/2026; 2 of 3 reactions were positive.

How often has Corvus Pharmaceuticals beaten expectations?

Corvus Pharmaceuticals has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Corvus Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.19
Actual:
Q2 2026
Missed
Estimate:-$0.16
Actual:-$0.19
Difference:-$0.03
Price reaction (1 day):+0.4 %
Q1 2026
Missed
Estimate:-$0.15
Actual:-$0.15
Difference:-$0.00
Price reaction (1 day):+6.6 %
Price reaction (7 days):-6.4 %
Q4 2025
Missed
Estimate:-$0.13
Actual:-$0.15
Difference:-$0.02
Price reaction (1 day):-4.3 %
Price reaction (7 days):-12.0 %
Q2 2025
Beat
Estimate:-$0.14
Actual:-$0.12
Difference:+$0.02
Q1 2025
Missed
Estimate:-$0.12
Actual:-$0.13
Difference:-$0.01

Earnings statistics

Stock reaction to earnings

±3.8%
Avg. next-day move
+6.6%
Largest move (05/07/2026)
66.7%
Share of positive reactions

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-7.5%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Corvus Pharmaceuticals
Ticker Symbol
CRVS
ISIN
US2210151005
Country
🇺🇸
USA
Sector